Clinical Trial Update: Sildenofil in Persistent Pulmonary Hypertension in Newborns [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating sildenafil for persistent pulmonary hypertension of the newborn is ongoing, sponsored by Hamad Medical Corporation, with the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Pulmonary Hypertension of the Newborn

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Hamad Medical Corporation | Conditions: Persistent Fetal Circulation Syndrome | Phase 3 | Status: UNKNOWN